APA (7th ed.) Citation

Bonnevaux, H., Guerif, S., Albrecht, J., Jouannot, E., Gallier, T. D., Beil, C., . . . Virone-Oddos, A. (2021, January). Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment. OncoImmunology.

Chicago Style (17th ed.) Citation

Bonnevaux, Hélène, et al. "Pre-clinical Development of a Novel CD3-CD123 Bispecific T-cell Engager Using Cross-over Dual-variable Domain (CODV) Format for Acute Myeloid Leukemia (AML) Treatment." OncoImmunology Jan. 2021.

MLA (9th ed.) Citation

Bonnevaux, Hélène, et al. "Pre-clinical Development of a Novel CD3-CD123 Bispecific T-cell Engager Using Cross-over Dual-variable Domain (CODV) Format for Acute Myeloid Leukemia (AML) Treatment." OncoImmunology, Jan. 2021.